Encouraging Preclinical Data from ARI-0003, a New Academic Dual CAR-T for NHL; Can ARI-0003 Repeat the Success of ARI-0001? MiNK Tx Presented Preclinical Data of MiNK-215 in NSCLC; ASCGT 2023 Analysis 3
Here is a brief preview of this blast: ASGCT 2023 Analysis 3: The Hospital Clinic of Barcelona presented preclinical data supporting the development of ARI-0003 (CD19 x BCMA CAR-T), its new academic cell therapy for the treatment of NHL patients. Moreover, MiNK Tx presented preclinical data of MiNK-215, the company’s FAP-targeting iNKT cell therapy. Bellow, Celltelligence provides insights and context for key selected presentations while discussing if ARI-0003 could replicate ARI-0001’s successful clinical development and point-of-care model.